FTO (fat mass and obesity associated) is a recently discovered gene related to obesity and expressed in various tissues of the human body, especially with high expression in the brain. Earlier studies have found that FTO is involved in several biological processes, including brain development and function. In particular, recent studies have found that FTO is a demethylase of N6-methyladenosine (m6A) and it can affect neurological function through the m6A modification of mRNA. At present, a number of studies have shown that FTO is associated with many neuropsychiatric disorders. This paper reviews the discovery, structure, function, and tissue expression of FTO followed by discussing the relationship between FTO and neuropsychiatric diseases. In addition, the potential roles of FTO gene in drug addiction, major depression (MDD), and schizophrenia (SCZ) through regulating m6A modification of dopamine related genes were also highlighted.
CITATION STYLE
Chang, R., Huang, Z., Zhao, S., Zou, J., Li, Y., & Tan, S. (2022). Emerging Roles of FTO in Neuropsychiatric Disorders. BioMed Research International. Hindawi Limited. https://doi.org/10.1155/2022/2677312
Mendeley helps you to discover research relevant for your work.